Dolsten Mikael
CIK 0001437590 Name as filed on the most recent filing
Filed as Dolsten Mikael (15)
71 transaction lines · from 15 filings · filed 2013-03-08 to 2026-06-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
71 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-29 |
Agilent Technologies, Inc. A |
S, Open-market sale | 1,600 disposed | 135.42 | 216,672.00 | Form 4, filing 0001090872-26-000057 | |
| 2025-12-01 |
Agilent Technologies, Inc. A |
S, Open-market sale | 2,600 disposed | 149.81 | 389,511.20 | Form 4, filing 0001090872-25-000083 | |
| 2022-05-11 |
Pfizer Inc PFE |
S, Open-market sale | 32,015 disposed | 49.31 | 1,578,659.65 | Form 4, filing 0001225208-22-006909 | |
| 2022-05-11 |
Pfizer Inc PFE |
S, Open-market sale | 18,562 disposed | 49.32 | 915,477.84 | Form 4, filing 0001225208-22-006909 | |
| 2022-05-11 |
Pfizer Inc PFE |
S, Open-market sale | 7,876 disposed | 49.33 | 388,523.08 | Form 4, filing 0001225208-22-006909 | |
| 2022-05-11 |
Pfizer Inc PFE |
S, Open-market sale | 2,891 disposed | 49.35 | 142,670.85 | Form 4, filing 0001225208-22-006909 | |
| 2022-05-11 |
Pfizer Inc PFE |
S, Open-market sale | 2,358 disposed | 49.34 | 116,343.72 | Form 4, filing 0001225208-22-006909 | |
| 2022-05-11 |
Pfizer Inc PFE |
S, Open-market sale | 200 disposed | 49.36 | 9,872.00 | Form 4, filing 0001225208-22-006909 | |
| 2021-11-11 |
Pfizer Inc PFE |
S, Open-market sale | 36,711 disposed | 50.28 | 1,845,829.08 | Form 4, filing 0001225208-21-013883 | |
| 2021-11-11 |
Pfizer Inc PFE |
S, Open-market sale | 6,708 disposed | 50.33 | 337,613.64 | Form 4, filing 0001225208-21-013883 | |
| 2021-11-11 |
Pfizer Inc PFE |
S, Open-market sale | 5,227 disposed | 50.29 | 262,865.83 | Form 4, filing 0001225208-21-013883 | |
| 2021-11-11 |
Pfizer Inc PFE |
S, Open-market sale | 3,396 disposed | 50.31 | 170,852.76 | Form 4, filing 0001225208-21-013883 | |
| 2021-11-11 |
Pfizer Inc PFE |
S, Open-market sale | 3,197 disposed | 50.29 | 160,777.13 | Form 4, filing 0001225208-21-013883 | |
| 2021-11-11 |
Pfizer Inc PFE |
S, Open-market sale | 2,301 disposed | 50.32 | 115,786.32 | Form 4, filing 0001225208-21-013883 | |
| 2021-11-11 |
Pfizer Inc PFE |
S, Open-market sale | 2,124 disposed | 50.34 | 106,922.16 | Form 4, filing 0001225208-21-013883 | |
| 2020-05-18 |
Pfizer Inc PFE |
S, Open-market sale | 24,242 disposed | 37.79 | 916,105.18 | Form 4, filing 0001225208-20-008008 | |
| 2020-05-18 |
Pfizer Inc PFE |
S, Open-market sale | 17,357 disposed | 37.78 | 655,747.46 | Form 4, filing 0001225208-20-008008 | |
| 2020-05-18 |
Pfizer Inc PFE |
S, Open-market sale | 16,840 disposed | 37.80 | 636,552.00 | Form 4, filing 0001225208-20-008008 | |
| 2020-05-18 |
Pfizer Inc PFE |
S, Open-market sale | 14,727 disposed | 37.77 | 556,238.79 | Form 4, filing 0001225208-20-008008 | |
| 2020-05-18 |
Pfizer Inc PFE |
S, Open-market sale | 9,700 disposed | 37.75 | 366,175.00 | Form 4, filing 0001225208-20-008008 | |
| 2020-05-18 |
Pfizer Inc PFE |
S, Open-market sale | 6,470 disposed | 37.81 | 244,630.70 | Form 4, filing 0001225208-20-008008 | |
| 2020-05-18 |
Pfizer Inc PFE |
S, Open-market sale | 5,517 disposed | 37.76 | 208,321.92 | Form 4, filing 0001225208-20-008008 | |
| 2020-05-18 |
Pfizer Inc PFE |
S, Open-market sale | 500 disposed | 37.82 | 18,910.00 | Form 4, filing 0001225208-20-008008 | |
| 2019-03-04 |
Pfizer Inc PFE |
S, Open-market sale | 38,645 disposed | 43.52 | 1,681,830.40 | Form 4, filing 0001225208-19-004612 | |
| 2019-03-04 |
Pfizer Inc PFE |
S, Open-market sale | 3,250 disposed | 43.53 | 141,472.50 | Form 4, filing 0001225208-19-004612 | |
| 2019-03-04 |
Pfizer Inc PFE |
S, Open-market sale | 2,600 disposed | 43.54 | 113,204.00 | Form 4, filing 0001225208-19-004612 | |
| 2019-03-04 |
Pfizer Inc PFE |
S, Open-market sale | 2,400 disposed | 43.55 | 104,520.00 | Form 4, filing 0001225208-19-004612 | |
| 2019-03-04 |
Pfizer Inc PFE |
S, Open-market sale | 2,187 disposed | 43.56 | 95,265.72 | Form 4, filing 0001225208-19-004612 | |
| 2019-03-01 |
Pfizer Inc PFE |
S, Open-market sale | 77,484 disposed | 43.56 | 3,375,203.04 | Form 4, filing 0001225208-19-004612 | |
| 2019-03-01 |
Pfizer Inc PFE |
S, Open-market sale | 14,760 disposed | 43.57 | 643,093.20 | Form 4, filing 0001225208-19-004612 | |
| 2019-03-01 |
Pfizer Inc PFE |
S, Open-market sale | 5,927 disposed | 43.58 | 258,298.66 | Form 4, filing 0001225208-19-004612 | |
| 2019-03-01 |
Pfizer Inc PFE |
S, Open-market sale | 2,300 disposed | 43.59 | 100,257.00 | Form 4, filing 0001225208-19-004612 | |
| 2018-03-09 |
Pfizer Inc PFE |
S, Open-market sale | 32,457 disposed | 36.61 | 1,188,250.77 | Form 4, filing 0001225208-18-005928 | |
| 2018-03-09 |
Pfizer Inc PFE |
S, Open-market sale | 15,459 disposed | 36.56 | 565,181.04 | Form 4, filing 0001225208-18-005928 | |
| 2018-03-09 |
Pfizer Inc PFE |
S, Open-market sale | 9,900 disposed | 36.60 | 362,340.00 | Form 4, filing 0001225208-18-005928 | |
| 2018-03-09 |
Pfizer Inc PFE |
S, Open-market sale | 5,300 disposed | 36.59 | 193,927.00 | Form 4, filing 0001225208-18-005928 | |
| 2018-03-09 |
Pfizer Inc PFE |
S, Open-market sale | 4,154 disposed | 36.57 | 151,911.78 | Form 4, filing 0001225208-18-005928 | |
| 2018-03-09 |
Pfizer Inc PFE |
S, Open-market sale | 2,329 disposed | 36.55 | 85,124.95 | Form 4, filing 0001225208-18-005928 | |
| 2018-03-09 |
Pfizer Inc PFE |
S, Open-market sale | 100 disposed | 36.58 | 3,658.00 | Form 4, filing 0001225208-18-005928 | |
| 2018-03-02 |
Pfizer Inc PFE |
S, Open-market sale | 13,986 disposed | 35.85 | 501,398.10 | Form 4, filing 0001225208-18-005203 | |
| 2018-02-27 |
Pfizer Inc PFE |
S, Open-market sale | 25,120 disposed | 37.03 | 930,193.60 | Form 4, filing 0001225208-18-004659 | |
| 2018-02-27 |
Pfizer Inc PFE |
S, Open-market sale | 22,291 disposed | 37.04 | 825,658.64 | Form 4, filing 0001225208-18-004659 | |
| 2018-02-27 |
Pfizer Inc PFE |
S, Open-market sale | 9,132 disposed | 37.06 | 338,431.92 | Form 4, filing 0001225208-18-004659 | |
| 2018-02-27 |
Pfizer Inc PFE |
S, Open-market sale | 7,844 disposed | 37.05 | 290,620.20 | Form 4, filing 0001225208-18-004659 | |
| 2018-02-27 |
Pfizer Inc PFE |
S, Open-market sale | 100 disposed | 37.07 | 3,707.00 | Form 4, filing 0001225208-18-004659 | |
| 2018-02-27 |
Pfizer Inc PFE |
S, Open-market sale | 100 disposed | 37.02 | 3,702.00 | Form 4, filing 0001225208-18-004659 | |
| 2017-03-02 |
Pfizer Inc PFE |
S, Open-market sale | 15,401 disposed | 34.55 | 532,104.55 | Form 4, filing 0001225208-17-005518 | |
| 2017-03-01 |
Pfizer Inc PFE |
S, Open-market sale | 15,569 disposed | 34.48 | 536,819.12 | Form 4, filing 0001225208-17-005518 | |
| 2017-02-27 |
Pfizer Inc PFE |
S, Open-market sale | 27,523 disposed | 34.26 | 942,937.98 | Form 4, filing 0001225208-17-005102 | |
| 2017-02-27 |
Pfizer Inc PFE |
S, Open-market sale | 24,668 disposed | 34.27 | 845,372.36 | Form 4, filing 0001225208-17-005102 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 0
- Open-market sale 71
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Dolsten Mikael, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001437590
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6